For effective prevention, vaccines must stimulate mucosal immunity – an immune response in the respiratory tract where ...

The vaccine, which is based on the ChAd3 simian adenoviral platform, achieved promising results in a Phase I clinical trial.

Gentle nasal spray vaccines against COVID, the flu and RSV are coming. They may work better than shots in the arm ...

The Virology, Vector and Vaccine Engineering Lab is working toward developing ... Current projects are directed toward targeting oncolytic adenovirus to breast cancer, chronic lymphocytic leukemia, ...

How it works Convidencia is a viral vector vaccine using adenovirus five. With a viral vector, there is essentially a viral particle, which is programmed not to replicate. So, what is administered ...

According to the latest information published by the World Health Organization, there are two vaccines in clinical trials against coronavirus. These are an adenovirus vector-based vaccine being ...